Logo Image
News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health PerspectivesShorts
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
Our June 2026 print issue|
Free Webinar: The Economics of Cell and Gene Therapy |
2026 ASCO Annual Meeting|
2026 State of Pharmacy survey results available now
Advertisement

Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Advertisement

Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Celltrion USA’s commitment to meeting patient demand for affordable and effective biologics

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
October 6th 2023

Sponsored Content

Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
July 5th 2023

Sponsored Content

Advertisement

Latest Updated Articles

  • Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars
    Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars

    July 5th 2023



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

FDA to review biosimilar of Entyvio

2

Researchers test single vaccine built to prevent future coronavirus pandemics

3

Rebate and adherence concerns drive payer reluctance on GLP-1 obesity coverage

4

Survodutide cuts visceral fat by 34%, liver fat by 63% in phase 3 trials | ADA 2026

5

Retatrutide shows substantial weight loss, glycemic control in obesity and type 2 diabetes | ADA 2026

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us